Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale...
09/05/22
- Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code GlobeNewswire
- Clarus pursues bankruptcy sale Daily Herald
- Clarus files for Chapter 11 bankruptcy protection, will sell testosterone deficiency drug Jatenzo Crain's Chicago Business
- Pharma Co. Clarus Hits Ch. 11 With Plan To Sell Sole Drug Law360
- $CRXT Clarus Therapeutics Holdings Announces Plan For Near-Term Sale Of Jatenzo Using Structured Process Through Chapter 11 Of The U.S. Bankruptcy Code CML News
- View Full Coverage on Google News